Journal of the American Society of Hypertension
Volume 2, Issue 3 , Pages 173-181, May 2008

Angiotensin-II-dependent NHE1 activation in human monocytes

  • Konstantinos Paletas, MD, PhD

      Affiliations

    • Metabolic Diseases Unit, Department of Internal Medicine, B'Medical Clinic, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • ,
  • Xenia Sailer, BSci

      Affiliations

    • Laboratory of Animal Physiology, Department of Zoology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • ,
  • Lina Rizeq, BSci

      Affiliations

    • Laboratory of Animal Physiology, Department of Zoology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • ,
  • Anastasia Dimitriadi

      Affiliations

    • Laboratory of Animal Physiology, Department of Zoology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • ,
  • George Koliakos, MD, PhD

      Affiliations

    • Laboratory of Biological Chemistry, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • ,
  • Martha Kaloyianni, PhD

      Affiliations

    • Laboratory of Animal Physiology, Department of Zoology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece
    • Corresponding Author InformationCorresponding author: Martha Kaloyianni, PhD, Aristotle University of Thessaloniki, School of Biology, Department of Zoology, Thessaloniki, Greece 54124. Tel: +30 2310 998271; fax: +30 2310 998269.

Received 10 July 2007; accepted 25 October 2007.

Abstract 

Angiotensin II, a potent vasoconstrictor, has been demonstrated to be involved in the pathogenesis of atherosclerosis, and its complications. Na+/H+ exchanger isoform-1 (NHE1) is related to hypertension activation and can augment atherosclerosis-related functions in human monocytes. The purpose of this study is to investigate in monocytes the signal transduction pathway induced by angiotensin II, in which the Na+/H+ exchanger (NHE1) takes part. Monocytes were isolated, and intracellular pH (pHi) was measured by the use of Bis-(carboxyethyl)-5(6)-carboxy-fluorescein acetoxymethylester. Superoxide anions were measured by nitroblue tetrazolium. Monocyte binding to laminin-1 was quantified using the myeloperoxidase assay. Angiotensin II caused a significant increase in pHi of monocytes, which indicates NHE activation. Cariporide, an NHE1 inhibitor, GF109203X, and Gö6976, inhibitors of isoforms of protein kinase C (PKC), diphenyleneiodonium chloride, the inhibitor of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, and Nω-Nitro-L-arginine methyl ester hydrochloride, the inhibitor of nitric oxide (NO) synthase, reversed this effect. Moreover, it was shown that angiotensin II caused an increase in superoxide ion (O2−.) levels as well as an increase in monocytes' adhesion to laminin-1, in relation to controls. The use of cariporide inhibited these effects. Furthermore, angiotensin II caused an increase in pHi, which was reversed by cariporide in monocytes derived from hypertensive patients. Consequently, in human monocytes angiotensin II caused NHE1 activation through pathways involving isoforms of PKC with the participation of O2−. and NO. In addition, a link between angiotensin II and the atherogenic properties of monocytes was shown, where NHE1 plays a central role.

Keywords: Hypertension, atherosclerosis, reactive oxygen species, signaling, intracellular pH

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was supported by Hellenic Society of Hypertension.

 Conflict of interest: none.

PII: S1933-1711(07)00228-8

doi:10.1016/j.jash.2007.10.010

Journal of the American Society of Hypertension
Volume 2, Issue 3 , Pages 173-181, May 2008